Novo Nordisk A/S (NVO)
Last Price$101.7(3.4%)
Market Cap$604.5B
Financial profile score
8/10
LTM Revenue
$37.3B
+6.4% YoY
LTM Net Income
$13.0B
+1.4% YoY
LTM Free Cash Flow
$9.5B
+33.2% YoY
Net Debt
$610.4M
Short-term financial position
0.9x
Current Assets / Current Liabilities
NVO Income statement
Crunching data... Almost there!
NVO Balance sheet
Crunching data... Almost there!
NVO Key balance sheet metrics
Crunching data... Almost there!
NVO Cash flow statement
Crunching data... Almost there!
NVO Key cash flow statement metrics
Crunching data... Almost there!
Discover more NVO fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What are Novo Nordisk A/S (NVO) Key Income Statement Metrics?
As of today, Novo Nordisk A/S last 12-month Revenue is $37.3B , EBITDA is $18.9B and Net Income is $13.0B , based on the financial report for Jun 30, 2024 (Q2 2024).
What are Novo Nordisk A/S (NVO) Key Balance Sheet Metrics?
As of today, Novo Nordisk A/S Total Assets are $53.2B and Total Liabilities are $37.0B , based on the financial report for Jun 30, 2024 (Q2 2024).
What are Novo Nordisk A/S (NVO) Key Cash Flow Statement Metrics?
As of today, Novo Nordisk A/S last 12-month Cash Flow from Operating Activities is $7,273.8M, Cash Flow from Investing Activities is ($2,985.8M) and Cash Flow from Financing Activities is $2,402.8M, based on the financial report for Jun 30, 2024 (Q2 2024).
What is Novo Nordisk A/S (NVO) Free Cash Flow?
As of today, Novo Nordisk A/S last 12-month Free Cash Flow is $9.5B , based on the financial report for Jun 30, 2024 (Q2 2024).